DVx Inc logo

3079 - DVx Inc Share Price

¥1037 -13.0  -1.2%

Last Trade - 7:00am

Small Cap
Market Cap £68.6m
Enterprise Value £31.0m
Revenue £277.5m
Position in Universe 2482nd / 3900
Unlock 3079 Revenue
Relative Strength (%)
1m -6.46%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
28,648 31,372 35,267 38,276 40,380 44,654 +9.3%
+16.9 +43.2 -24.7 -5.7 +5.7 -12.8
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, DVx Inc.revenues decreased 9% to Y30.49B. Net income applicable tocommon stockholders decreased 27% to Y399M. Revenuesreflect Arrhythmia Business segment decrease of 10% toY26.25B, Ischemia Business segment decrease of 20% toY2.36B. Net income also reflects Salaries And Allowanceincrease of 4% to Y1.16B (expense), Provision Of ReserveFor Bonus increase of 12% to Y133.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


3079 Revenue Unlock 3079 Revenue

Net Income

3079 Net Income Unlock 3079 Revenue

Normalised EPS

3079 Normalised EPS Unlock 3079 Revenue

PE Ratio Range

3079 PE Ratio Range Unlock 3079 Revenue

Dividend Yield Range

3079 Dividend Yield Range Unlock 3079 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
3079 EPS Forecasts Unlock 3079 Revenue
Profile Summary

DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated April 1, 1986
Public Since April 25, 2007
No. of Shareholders: 6,021
No. of Employees: 322
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Tokyo Stock Exchange
Shares in Issue 9,802,656
Free Float (0.0%)
Eligible for
3079 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 3079
Upcoming Events for 3079
Thursday 24th June, 2021 Estimate
DVx Inc Annual Shareholders Meeting
Frequently Asked Questions for DVx Inc
What is the DVx Inc share price?

As of 7:00am, shares in DVx Inc are trading at ¥1037, giving the company a market capitalisation of £68.6m. This share price information is delayed by 15 minutes.

How has the DVx Inc share price performed this year?

Shares in DVx Inc are currently trading at ¥1037 and the price has moved by 21.81% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the DVx Inc price has moved by -19.66% over the past year.

What are the analyst and broker recommendations for DVx Inc?

Of the analysts with advisory recommendations for DVx Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for DVx Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will DVx Inc next release its financial results?

DVx Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the DVx Inc dividend yield?

The DVx Inc dividend yield is 2.29% based on the trailing twelve month period.

Does DVx Inc pay a dividend?

Last year, DVx Inc paid a total dividend of 24, and it currently has a trailing dividend yield of 2.29%. Looking ahead, DVx Inc has not announced an ex-dividend date yet and the next dividend pay date is 2021-06-01.

When does DVx Inc next pay dividends?

DVx Inc has yet to annouce their ex-dividend date and the next dividend pay date is 2021-06-01. The historic dividend yield on DVx Inc shares is currently 2.29%.

How do I buy DVx Inc shares?

To buy shares in DVx Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of DVx Inc?

Shares in DVx Inc are currently trading at ¥1037, giving the company a market capitalisation of £68.6m.

Where are DVx Inc shares listed? Where are DVx Inc shares listed?

Here are the trading details for DVx Inc:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 3079
What kind of share is DVx Inc?

Based on an overall assessment of its quality, value and momentum, DVx Inc is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a DVx Inc share price forecast 2021?

We were not able to load any forecast data for DVx Inc.

How can I tell whether the DVx Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DVx Inc. Over the past six months, the relative strength of its shares against the market has been -17.96%. At the current price of ¥1037, shares in DVx Inc are trading at 4.38% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the DVx Inc PE Ratio?

The DVx Inc PE ratio based on its reported earnings over the past 12 months is 16.24. The shares are currently trading at ¥1037.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of DVx Inc?

DVx Inc's management team is headed by:

Makoto Wakabayashi - CHM
Masayuki Nabeya - EXO
Hiroshi Shibazaki - MDR
Hiroki Matsumoto - EXO
Mitsuharu Muramatsu - IND
Tomohisa Izutani - EXO
Kazuyuki Nakano - EXO
Naohiro Hirano - EXO
Toshihiko Azuma - EXO
Shigeru Chiba - PRE
Shigeharu Dogakinai - IND
Satoshi Miyamoto - EXO
Who are the major shareholders of DVx Inc?

Here are the top five shareholders of DVx Inc based on the size of their shareholding:

KK MSS Corporation
Percentage owned: 31.58% (3.40m shares)
Hikari Tsushin KK Corporation
Percentage owned: 6.47% (698k shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 6.13% (661k shares)
Fidelity Low-Priced Stock Fund Mutual Fund
Percentage owned: 6.12% (660k shares)
Wakabayashi (Inami) Individual Investor
Percentage owned: 2.99% (322k shares)
Similar to 3079
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.